[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-334516-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-334516-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","the-recombinant-l-lysine-oxidase-from-the-fungus-trichoderma-harzianum-promotes-apoptosis-and-necrosis-of-leukemia-cd34-hematopoietic-cells","The recombinant l-lysine α-oxidase from the fungus Trichoderma harzianum promotes apoptosis and necrosis of leukemia CD34+ hematopoietic cells","","Hematologic cancers, including leukemia, rely on amino acids to support rapid proliferation. Amino-acid deprivation can suppress growth, induce autophagy, and trigger programmed cell death, making amino-acid metabolism a therapeutic opportunity. l-Lysine is essential for tumor growth and has been explored as a target, while l-lysine α-oxidase (a flavoenzyme that degrades l-lysine) is studied for its ability to promote apoptosis and inhibit cancer cell proliferation. This work uses l-lysine α-oxidase from Trichoderma harzianum for leukemia treatment, characterizing its effects on leukemic CD34+ cells.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/the-recombinant-l-lysine-oxidase-from-the-fungus-trichoderma-harzianum-promotes-apoptosis-and-necrosis-of-leukemia-cd34-hematopoietic-cells/334516/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/the-recombinant-l-lysine-oxidase-from-the-fungus-trichoderma-harzianum-promotes-apoptosis-and-necrosis-of-leukemia-cd34-hematopoietic-cells/334516.png","ImageObject",300,407,{"name":42,"@type":43},"Patrick","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-03","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",15,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why are amino acids important in leukemia cell growth?","Question",{"text":63,"@type":64},"Leukemia cells depend on amino acids to sustain rapid proliferation. Depriving specific amino acids can inhibit growth, promote autophagy, and activate programmed cell death pathways.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What is l-lysine α-oxidase and what does it do?",{"text":68,"@type":64},"l-lysine α-oxidase is a flavoenzyme that degrades l-lysine. By reducing l-lysine availability, it can interfere with tumor metabolism and contribute to apoptosis and reduced proliferation.",{"name":70,"@type":61,"acceptedAnswer":71},"What were the key findings of using the recombinant l-lysine α-oxidase from Trichoderma harzianum?",{"text":72,"@type":64},"A novel l-lysine α-oxidase was identified and characterized, and the recombinant protein showed potent and selective cytotoxic effects on leukemic cells. The cytotoxicity was associated with apoptotic cascade activation via mitochondrial dysfunction.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},334516,1790168539,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":109,"preview_page_count":4},549758146520,"https://ap-avatar.wpscdn.com/avatar/80002397d8c0411e94?_k=1775819394049821470","Costa et al. Microbial Cell Factories (2024) 23:51 [https://doi.org/10.1186/s12934-024-02315-2](https://doi.org/10.1186/s12934-024-02315-2)  \nMicrobial Cell Factories  \n RESEARCH Open Access  \nThe recombinant l-lysine α-oxidase  \nfrom the fungus Trichodermaharzianum promotes apoptosis and necrosis of leukemia CD34 + hematopoietic cells  \nMariana do Nascimento Costa1, Thiago Aparecido Silva2,3, Dimitrius Santiago Passos Simões Fróes Guimarães4, Rafael Ricci‑Azevedo2, Felipe Roberti Teixeira5, Leonardo Reis Silveira4, Marcelo Damário Gomes1,  \nVítor Marcel Faça 1, Eduardo Brandt de Oliveira1, Rodrigo T. Calado6 and Roberto N. Silva 1*  \nAbstract  \nBackground In hematologic cancers, including leukemia, cells depend on amino acids for rapid growth. Anti‑ metabolites that prevent their synthesis or promote their degradation are considered potential cancer treatment agents. Amino acid deprivation triggers proliferation inhibition, autophagy, and programmed cell death. l‑lysine, an essential amino acid, is required for tumor growth and has been investigated for its potential as a target for cancer treatment. l‑lysine α‑oxidase, a flavoenzyme that degrades l‑lysine, has been studied for its ability to induce apoptosis and prevent cancer cell proliferation. In this study, we describe the use of l‑lysine α‑oxidase (LO) from the filamentous fungus Trichoderma harzianum for cancer treatment.  \nResults The study identified and characterized a novel LO from T. harzianum and demonstrated that the recombinant protein (rLO) has potent and selective cytotoxic effects on leukemic cells by triggering the apoptotic cascade through mitochondrial dysfunction.  \nConclusions The results support future translational studies using the recombinant LO as a potential drug  \nfor the treatment of leukemia.  \nKeywords Leukemia, l‑lysine α‑oxidase, Trichoderma harzianum, Cancer treatment  \n*Correspondence: Roberto N. Silva [rsilva@fmrp.usp.br](rsilva@fmrp.usp.br)  \n1 Department of Biochemistry and Immunology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, SP, Brazil  \n2 Department of Cell Biology and Molecular and Pathogenic Bioagents, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, SP, Brazil  \n3 Department of Clinical Analysis, School of Pharmaceutical Sciences in Araraquara, Sao Paulo State University, Araraquara, SP, Brazil  \n4 Obesity and Comorbidities Research Center, Institute of Biology, University of Campinas, Campinas, SP, Brazil  \n5 Department of Genetics and Evolution, Center of Biological and Health Sciences, Federal University of São Carlos, São Carlos, SP, Brazil  \n6 Department of Medical Imaging, Hematology, and Oncology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, SP, Brazil  \n© The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/licenses/by/4.0/](http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver ()[. The Creative Commons Public Domain Dedication waiver (](http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver ()[http://creativeco](http://creativeco)[mmons.org/publicdomain/zero/1.0/](mmons.or","cbCaisOC8j5QSVgr","https://ap.wps.com/l/cbCaisOC8j5QSVgr","pdf",2431980,16,"English","# Abstract\n## Background\n## Results\n## Conclusions\n# Background\n## Metabolic regulation and malignant growth\n## Amino-acid deprivation as a cancer strategy\n# Study focus\n## Recombinant l-lysine α-oxidase for leukemia therapy","[{\"question\":\"Why are amino acids important in leukemia cell growth?\",\"answer\":\"Leukemia cells depend on amino acids to sustain rapid proliferation. Depriving specific amino acids can inhibit growth, promote autophagy, and activate programmed cell death pathways.\"},{\"question\":\"What is l-lysine α-oxidase and what does it do?\",\"answer\":\"l-lysine α-oxidase is a flavoenzyme that degrades l-lysine. By reducing l-lysine availability, it can interfere with tumor metabolism and contribute to apoptosis and reduced proliferation.\"},{\"question\":\"What were the key findings of using the recombinant l-lysine α-oxidase from Trichoderma harzianum?\",\"answer\":\"A novel l-lysine α-oxidase was identified and characterized, and the recombinant protein showed potent and selective cytotoxic effects on leukemic cells. The cytotoxicity was associated with apoptotic cascade activation via mitochondrial dysfunction.\"}]","The recombinant l-lysine α-oxidase from the fungus Trichoderma harzianum promotes apoptosis and necrosis of leukemia CD34+ hematopoietic cells | PDF",1790007021]